Board of Directors
Home / Board of Directors
Standing audit, compliance, and science committees report quarterly to the full board, chaired by Andrew James Ball.
Andrew brings over two decades of cross-border governance experience to Seven Pharmacist, having chaired audit and risk committees across healthcare and financial services boards. He leads the board's oversight of long-term strategy, regulatory standing, and executive accountability, and chairs the Nominating & Governance Committee.
Joined the board in 2017. Direct line: +1 (415) 815-4998
Contact the BoardOne photo (Henry Westbrook) is still pending upload — all others below are final.
Co-founder. Previously led portfolio strategy at a top-five generics manufacturer.
Chartered accountant; former CFO of a publicly listed diagnostics company.
Professor of molecular pharmacology; advisor on biologics review.
Former head of market access at a multinational payer network.
Former federal regulatory counsel; oversees safety and compliance reporting.
Operating partner at a healthcare-focused growth equity firm.
Specialist in clinical trial design; former health technology assessment lead.
Co-founder. Previously led corporate development for a specialty pharmaceutical group.
Five standing committees report directly to the board on a quarterly cycle.
Chaired by Nadia Farouk.
Chaired by Helena Voss.
Chaired by Priya Nair.
Reviews pay structure annually.
Chaired by Andrew James Ball.
What struck me about Seven Pharmacist wasn't just the science — it was how seriously the board took its oversight role. Every milestone we hit as a partner was checked against real data, not just a press release.Dr. Lena Marsh, Former FDA Reviewer